A 2019 assessment observed that omega?3 fatty acid supplements make little if any distinction to cardiovascular mortality and that those with myocardial infarction have no gain in taking the nutritional supplements.The FDA’s reliance on consumer charges and could now feel entrenched and irrevocable. But Each and every PDUFA reauthorization cycle